about
Guidelines for the use and interpretation of assays for monitoring autophagyDeficiency of the zinc finger protein ZFP106 causes motor and sensory neurodegeneration.Analysis of Individual Mouse Activity in Group Housed Animals of Different Inbred Strains using a Novel Automated Home Cage Analysis SystemNovel gene function revealed by mouse mutagenesis screens for models of age-related disease.Loss-of-Function Mutations in FRRS1L Lead to an Epileptic-Dyskinetic EncephalopathyOtitis media in the Tgif knockout mouse implicates TGFβ signalling in chronic middle ear inflammatory disease.A comprehensive assessment of the SOD1G93A low-copy transgenic mouse, which models human amyotrophic lateral sclerosis.Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse.Novel mutations in human and mouse SCN4A implicate AMPK in myotonia and periodic paralysis.A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicityEstrogen modulates norepinephrine-induced accumulation of adenosine cyclic monophosphate in a subpopulation of immortalized luteinizing hormone-releasing hormone secreting neurons from the mouse hypothalamus.Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease.Reducing Igf-1r levels leads to paradoxical and sexually dimorphic effects in HD mice.Dynein mutations impair autophagic clearance of aggregate-prone proteins.α-Synuclein impairs macroautophagy: implications for Parkinson's disease.α-Synuclein levels modulate Huntington's disease in mice.Dyneins, autophagy, aggregation and neurodegeneration.ENU mutagenesis, a way forward to understand gene function.A nonsense mutation in mouse Tardbp affects TDP43 alternative splicing activity and causes limb-clasping and body tone defects.Widespread RNA metabolism impairment in sporadic inclusion body myositis TDP43-proteinopathy.SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.α-Synuclein levels affect autophagosome numbers in vivo and modulate Huntington disease pathology.IGF-1 receptor antagonism inhibits autophagy.Cancer modifier alleles inhibiting lung tumorigenesis are common in inbred mouse strains.Effects of dopaminergic cell degeneration on electrophysiological characteristics and GAD65/GAD67 expression in the substantia nigra: different action on GABA cell subpopulations.Haplotype sharing suggests that a genomic segment containing six genes accounts for the pulmonary adenoma susceptibility 1 (Pas1) locus activity in mice.Pramipexole reduces soluble mutant huntingtin and protects striatal neurons through dopamine D3 receptors in a genetic model of Huntington's disease.α-Synuclein levels modulate Huntington's disease in mice.Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in 'FUSDelta14' knockin mice.Towards humane end points: behavioural changes precede clinical signs of disease in a Huntington's disease model.A genetic modifier suggests that endurance exercise exacerbates Huntington's disease.A new locus for resistance to gamma-radiation-induced thymic lymphoma identified using inter-specific consomic and inter-specific recombinant congenic strains of mice.Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.TDP-43 mutations increase HNRNP A1-7B through gain of splicing functionSkeletal Muscle Modulates Huntington's Disease Pathogenesis in Mice: Role of Physical ExerciseTransgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosisLoss of disrupts synaptic AMPA receptor function, and results in neurodevelopmental, motor, cognitive and electrographical abnormalitiesGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndromeInhibition of the mTOR pathway: A new mechanism of β cell toxicity induced by tacrolimus
P50
Q21996341-71C23CDA-41BF-46CA-A004-33CBDC714FB9Q27300826-F480AA56-8585-4497-B4BF-565ECA58930DQ27320849-059DB50E-3018-4F21-A1A0-4FBF8F5A3F30Q27333508-3A8E9D6A-307C-4298-A9D6-5636B30865F1Q28115010-9DD8379E-0072-47EC-B2B7-726EFE1AABA7Q30453755-C34B16F0-ADE9-4C39-A5E6-79B2B02F438CQ30473769-F638D8FF-6074-4579-92B1-C2F0F65C8DA4Q30500276-8DBAB91B-D6E0-4962-A7B1-2C8AFD9136E0Q30600757-DFFBB0D8-991D-4983-AEA0-114756CF8E66Q30626279-820FB7CA-E2E4-4F80-93AF-0232F4FC1518Q31822986-558CA9EF-A232-4F34-90FC-1B5874508B6CQ33832866-E8C4125C-0183-4D8C-9AE0-28C1D5FA3250Q34070946-0010ECFE-D133-42A9-BDC5-06B846E1B929Q34429194-CA1E2D5B-F560-4D3E-B53A-BBFAD5AF249CQ35005567-00864748-A158-4851-9FD9-8AA747B69510Q35674687-252939DF-E50C-44A3-9DC8-6789867DDF8AQ36549501-672CFC44-6B17-4CD7-881A-AE9AA674C8C1Q37307784-17FA8ACF-CCE6-4F56-B78E-2A1CF1AEBBE9Q37499894-C4FA05F1-C534-4761-8CC9-C557ABEDD668Q37706412-96A46BA7-EFF1-4B76-B21F-F4CE983E4965Q37894600-7958C266-7B90-48E6-ACDF-108A9F8AB997Q37987766-F9069248-91E7-427E-9627-2D32335ADBB4Q39134341-FE0AE929-E872-496D-89DC-09CE3FD861DEQ43981230-DAADADCE-9718-4941-ACBE-9A32CC9E54DCQ44351572-7A7B2F29-600A-4999-94E8-C5DE12440802Q44830433-6FCE4955-7437-4A3A-9747-77F8DBD11CD1Q45305079-6A5059DD-0979-44D9-8EF5-A309896CC59AQ46623697-3D8F6AE0-0BE7-42DE-85A4-B716ECBB033DQ47623937-94CB44BF-56B7-468D-8EB3-88AFB71BB4EFQ51703519-2C0FEE19-5956-421F-8AA8-B72BB9FB8F92Q52671800-9BD9DF29-55DA-4F6D-969C-818D305245D0Q53958245-7EC5EC66-0314-4642-B604-4A4948288C06Q54989348-0F07DD0B-CFEA-4B4C-B2AA-7F3D3DEAF1A3Q58553474-E699D25F-24D4-411E-896A-ECBCBFD7CB42Q58593129-BC52B68B-41D5-427F-A177-79F606593284Q61807545-9D40CF22-1922-45E3-8977-9EFD90E1F9CAQ64110188-564AC0DD-DF4B-40C1-8740-10DC29F87E33Q87139132-E6A1B8DF-C634-4316-B341-15CA22E1E1CBQ92450823-BF9589A4-38FF-44A0-8264-C8293EE8919EQ92453940-D1891A43-CE11-49F8-B6C0-230E7400E53B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Abraham Acevedo-Arozena
@ast
Abraham Acevedo-Arozena
@en
Abraham Acevedo-Arozena
@es
Abraham Acevedo-Arozena
@nl
Abraham Acevedo-Arozena
@sl
type
label
Abraham Acevedo-Arozena
@ast
Abraham Acevedo-Arozena
@en
Abraham Acevedo-Arozena
@es
Abraham Acevedo-Arozena
@nl
Abraham Acevedo-Arozena
@sl
prefLabel
Abraham Acevedo-Arozena
@ast
Abraham Acevedo-Arozena
@en
Abraham Acevedo-Arozena
@es
Abraham Acevedo-Arozena
@nl
Abraham Acevedo-Arozena
@sl
P106
P21
P31
P496
0000-0001-6127-7116